Along with these findings, the finding by Keizman and colleagues that EGFR expression has prognostic value in both NF-1–associated and sporadic MPNST suggests that EGFR-targeted therapy may be a potential treatment for MPNST [11]. Here, NF1 is linked to malignant peripheral nerve sheath tumor.